جست‌وجوی استاد و پژوهشگر

Joonseong Leeمشاهده پروفایل

استاد

• Media Studies
• New Media Technologies
• Cultural Studies
• +۷ مورد دیگر

Dr. Joonseong Lee is a Professor in the Department of Communication & Media Studies at California State University San Marcos, part of the College of Humanities, Arts, Behavioral and Social Sciences (CHABSS). His office is located in SBSB 2128, and he can be contacted via email at jlee@csusm.edu or phone at (760) 750-4134. Education Ph.D. in Media Studies (2006) from Ohio University, School of Media Arts and Studies M.A. in Radio and Television (2002) from San Francisco State University, College of Creative Arts B.A. in Won Buddhism (1988) from Won Kwang University, Korea, focusing on Buddhism and social movements Research Focus Dr. Lee specializes in media, religion, and pop culture with expertise in emerging media and Eastern philosophy. His research combines Continental philosophy with Buddhist and Taoist frameworks to analyze: New media technologies and governmental dominance Feminist media studies and cyberculture empowerment Korean shamanism's mediatization and territorialization processes Cultural implications of digital spirituality and online rituals His groundbreaking 2022 book The Assemblage of Korean Shamanism examines shamanic practices through Deleuzian frameworks, with forthcoming research on artist Nam June Paik as an 'electronic shaman' (2025). Publication Focus Dr. Lee's scholarly work consistently explores the intersection of traditional Korean culture with digital modernity. His publications demonstrate: Recurrent analysis of shamanism's adaptation to digital capitalism Critical examination of gender politics in online spaces Interdisciplinary approaches combining media theory with religious studies Sustained focus on Korean cultural identity in globalized media landscapes Methodological innovation in studying cybercultures and digital ethnography Teaching Portfolio MDIA 360: Media and Society MDIA 301: Media Theory MDIA 304: Global Media MDIA 451: Media, Religion & Pop Culture MDIA 452: Media Ethics

• Inflammation
• Thrombosis
• Vascular Biology
• +۷ مورد دیگر

Professor Felicity N.E. Gavins is a Professor of Pharmacology and Royal Society Wolfson Fellow at Brunel University London, where she serves as Director of The Centre for Inflammation Research and Translational Medicine (CIRTM) within the College of Health, Medicine and Life Sciences. Her research focuses on unraveling the complexities of immune responses in vascular inflammation and thrombosis to improve treatment of human diseases, with particular emphasis on developing precision-targeted therapies that enhance inflammation resolution and mitigate chronic disease progression. Professor Gavins completed her BSc (Hons) in Pharmacology at the University of Sunderland, including an industrial placement year at Bayer Pharmaceuticals. She earned her PhD in Pharmacology from Queen Mary University London with British Heart Foundation (BHF) support. Her academic career includes a BHF Junior Research Fellowship, a lectureship at Imperial College London where she later became Deputy Head of the Centre of Neurodegeneration & Neuroinflammation, a tenured position at Louisiana State University Health Sciences Center-Shreveport, and her current role at Brunel University London since 2019. Her research program bridges integrative physiology and pharmacology with AI-driven discovery, focusing on the molecular and cellular mechanisms driving immune communication in vascular inflammation. A central theme is the Annexin A1-Formyl Peptide Receptor-2 (AnxA1-FPR2) pathway, a vital endogenous axis for resolving inflammation. Her lab employs state-of-the-art techniques including high-resolution in vivo imaging, AI-enabled single-cell immunophenotyping, and multi-omics approaches to investigate neutrophil and platelet dynamics in conditions such as stroke, sickle cell disease, and cardiovascular pathologies. The lab is committed to translating discoveries into clinical applications while minimizing animal model reliance through New Approach Methodologies (NAMs). Professor Gavins' recent publications demonstrate a strong focus on thromboinflammation, particularly in the context of viral infections like COVID-19, sickle cell disease, and stroke. Her work consistently explores how to harness the body's innate pro-resolving pathways to develop next-generation therapeutics. The research shows an increasing integration of computational approaches with traditional experimental methods, reflecting a trend toward more data-driven discovery in inflammation research. Fellow of the British Pharmacological Society (FBPhS) Fellow of the Royal Society of Biology (FRSB) Fellow Higher Education Academy (FHEA) Royal Society Wolfson Fellow Professor Gavins actively supervises multiple PhD students working on diverse projects related to inflammation resolution, including FPR2 agonism for stroke treatment, promoting inflammation resolution in cardiovascular pathologies, and developing non-mammalian models for thrombosis research. Her lab receives funding from prestigious sources including the British Heart Foundation and Dean's Studentships at Brunel University. She is committed to mentoring post-doctoral research fellows and early-career investigators, with several alumni now holding independent research positions. The Gavins Lab operates as a hub for interdisciplinary research, featuring a diverse team of PhD students, a data scientist, and undergraduate interns. The lab has established a wide global network of collaborations with leading scientists including Professor Paul Kubes at University of Calgary, Professor Rafal Pawlinski at University of North Carolina, and Professor Charles Serhan at Harvard Medical School. The lab is also committed to sustainable science practices through the My Green Lab initiative, implementing measures to reduce single-use plastics, optimize energy efficiency, and choose sustainable reagents.

Dania Moviaمشاهده پروفایل

استادیار

• Biomedical Engineering
• Toxicology
• Cancer Research
• +۵ مورد دیگر

Dr. Dania Movia is an Assistant Professor in Biomedical & Health Services at Maynooth University's Department of Biology, serving as Principal Investigator at the Kathleen Lonsdale Institute for Human Health Research. She also holds an Adjunct Assistant Professorship at Trinity College Dublin's Radiation Therapy Discipline. Her research focuses on advancing respiratory research and replacing animal testing through New Approach Methodologies (NAMs). Education: MSc in Chemistry and Pharmaceutical Technologies, University of Trieste (2007) PhD in Chemistry, Trinity College Dublin (2012) Special Purpose Certificate in Academic Practice, Trinity College Dublin (2018) Master of Arts (jure officii), Trinity College Dublin (2023) Research Interests: Dr. Movia advocates for sustainable biomedical research via animal-free technologies, particularly in lung cancer and toxicity studies. She leads Ireland's first wet-lab dedicated to animal-free respiratory research, the Humane Biomedical Research Group. Her work includes developing 3D tissue models and extracellular vesicle-based therapeutics. Over €23M in funding has supported her projects, including €2M as Principal Investigator. Publications & Awards: With over 50 peer-reviewed articles, she co-edited Cancer Cell Culture and serves as Associate Editor for Frontiers in Pharmacology . Notable awards include the 2025 Animal-Free Research UK Outstanding Scientist Award and inclusion in the 2021 Irish Hospital Professional News Top 100. Grants & Funding: Major funders include the Irish Research Council, Science Foundation Ireland, and the European Commission. Key projects include INSPIRE (€12.8M) for lung cancer therapies and 3Rs-focused initiatives. Labs & Teams: Leads the Humane Biomedical Research Group, which develops animal-free preclinical models and translational therapies. Collaborates internationally through COST Action CA21139 and scientific advisory roles with Animal-Free Research UK.

Katya Tsaiounمشاهده پروفایل

پژوهشگر

• evidence-based methodologies
• evidence-based toxicology
• translational research
• +۵ مورد دیگر

Katya Tsaioun, PhD, MS is an Assistant Scientist at Johns Hopkins University's Bloomberg School of Public Health, with primary departmental affiliation in Environmental Health and Engineering. She serves as Director of the Evidence-Based Toxicology Collaboration (EBTC) and is affiliated with the Center for Alternatives to Animal Testing (CAAT). Her work focuses on establishing evidence-based methodologies in translational research to inform regulatory decisions in environmental and public health. PhD in Human Nutrition Science from Tufts University Friedman School of Nutrition Science and Policy (1999) Post-doctoral training in neurochemistry at Harvard Medical School MS from Leningrad Institute of Technology (1987) Dr. Tsaioun's research is centered on evidence-based methodologies in toxicology, with expertise in translating scientific innovations into policies and technologies that improve public health. Her work spans systematic review methods, evidence-based toxicology, and the development of alternative testing approaches that reduce reliance on animal models. She has made significant contributions to the application of evidence-based methods in environmental health risk assessment and the development of frameworks for decision-making in regulatory contexts. Analysis of her recent publications reveals a strong focus on advancing evidence-based approaches in toxicology and environmental health. Her work consistently addresses the development and implementation of systematic review methodologies, evidence-to-decision frameworks, and alternative testing strategies. Key trends include the evolution of the GRADE framework for environmental health applications, the implementation of New Approach Methodologies (NAMs) in regulatory toxicology, and the advancement of systematic review practices in environmental health research. Dr. Tsaioun has extensive experience bridging academic research, industry applications, and regulatory science. Before joining Johns Hopkins, she spent nearly two decades in the pharmaceutical industry leading translational drug-discovery teams. She founded Apredica, a company that became a leader in commercializing de-risking technologies, which was later acquired by Cyprotex (now Evotec), where she served as CSO and Board member. She currently serves on advisory boards and review committees for numerous governmental, commercial, and non-profit organizations, contributing her expertise in evidence-based methodologies and translational research. As Director of the Evidence-Based Toxicology Collaboration, Dr. Tsaioun leads international multi-stakeholder efforts to establish evidence-based practices in translational research. Her work connects with various initiatives including the 3Rs principles (Replacement, Reduction, Refinement of animal testing), exposome research, and the development of alternative chemical testing strategies. She is actively involved in advancing the science of systematic reviews in toxicology and environmental health, with particular emphasis on improving the quality and applicability of evidence for regulatory decision-making.

Tamara Talمشاهده پروفایل

استاد

• Developmental Neurotoxicity
• Molecular Toxicology
• Chemical-Microbiome Interactions
• +۴ مورد دیگر

Professor Tamara Tal is a leading researcher in toxicology currently holding dual appointments as Professor of Integrated Systems Toxicology at the University of Leipzig Faculty of Medicine and Group Leader of the Molecular Toxicology Group at the Helmholtz Centre for Environmental Research - UFZ in Leipzig, Germany. Her research program focuses on developing new approach methodologies for neurotoxicity assessment, resolving molecular mechanisms of chemical toxicity, and investigating chemical-microbiome interactions affecting host outcomes. Dr. Tal received her PhD in Toxicology from the University of North Carolina Chapel Hill (2003-2008), followed by postdoctoral training at Oregon State University (2008-2011) and the US Environmental Protection Agency (2011-2015), where she later served as Principal Investigator (2015-2019). Her groundbreaking work has established zebrafish as a powerful model for high-throughput screening of environmental chemicals, particularly for developmental neurotoxicity assessment. Her research interests center on three interconnected areas: developing new approach methods (NAMs) for developmental neurotoxicity, using molecular approaches to resolve mechanisms of chemical-induced adverse outcomes, and investigating how chemical-microbiome interactions affect host toxicity. She has made significant contributions to understanding PFAS toxicity mechanisms, particularly how these 'forever chemicals' affect neurodevelopment through GABA receptor antagonism and microbiome disruption. Analysis of her recent publications (2021-2025) reveals a strong trend toward multi-behavioral phenotyping in zebrafish to identify subtle neurotoxic effects, investigation of chemical-microbiome interactions in toxicity pathways, and development of regulatory-ready testing methodologies. Her work bridges molecular mechanisms with organism-level outcomes, frequently employing the CITEPro high-throughput platform at UFZ for chemical screening. Helmholtz W2 Award (2021-2026) for NEURO-XENO-MICROBIOME project Paper of the Year Award, Society of Toxicology (2020) US EPA Science and Technological Achievement Award (2017) Multiple first-place awards from Society of Toxicology (2015) Dr. Tal leads the MibiTox project investigating the intestinal microbiome's role in pesticide-induced disease pathogenesis and contributes significantly to the PARC work package 5 project developing new neurotoxicity assessment methods for regulatory use. Her laboratory leverages the CITEPro platform for high-throughput sample preparation, automated exposure systems, and effect analysis, enabling comprehensive chemical screening while maintaining biological relevance.

Terje Svingenمشاهده پروفایل

استاد

• Endocrine Disrupting Chemicals
• Molecular Toxicology
• Reproductive Toxicology
• +۱۰ مورد دیگر

Terje Svingen is a Professor and Head of the Research Group for Molecular and Reproductive Toxicology at the National Food Institute, Technical University of Denmark (DTU). He has held this position since September 2023, following an appointment as Associate Professor from July 2017 to August 2023. His research is centered on understanding how environmental chemicals, particularly endocrine-disrupting compounds, affect development and reproductive health. His educational background includes a PhD in Molecular Biology (2001–2005), a Bachelor of Science with First-Class Honours (2000–2001), and a Bachelor of Science in Biotechnology (1997–1999), all from Griffith University, Australia. Svingen’s research integrates molecular and developmental biology to uncover the mechanisms by which endocrine disruptors interfere with normal development and tissue homeostasis. His work emphasizes the developmental window of susceptibility, gonad development, sex determination, and testis cancer. He is deeply involved in advancing regulatory toxicology through the use of New Approach Methodologies (NAMs) to improve chemical safety assessment. His recent publications (2025) reflect a strong focus on endocrine disruptors, reproductive health, regulatory frameworks in the EU, and the application of alternative testing methods. These works appear in high-impact journals such as Nature Reviews Endocrinology , Regulatory Toxicology and Pharmacology , and Frontiers in Toxicology , highlighting trends toward interdisciplinary, policy-relevant toxicological research. He has received no explicitly mentioned scientific awards in the provided text. Svingen actively supervises PhD students, including Despicht, C. and Stub, M. H., and leads major research projects such as NeXED, PeT, and MERLON, which involve significant funding and international collaboration. His work is supported by grants focused on reproductive toxicity, endocrine disruptor identification, and non-animal testing methods. He is a principal investigator in multiple active research initiatives and contributes to scientific discourse through conference presentations and editorial roles. His lab, the Research Group for Molecular and Reproductive Toxicology, operates within the National Food Institute at DTU, focusing on mechanistic toxicology and regulatory science.

Maxime Culotمشاهده پروفایل

استاد

• Pharmacology
• Toxicology
• Cell Biology
• +۳ مورد دیگر

Maxime Culot is a Professor at the Faculty of Sciences, University of Artois in Lens, France. He earned his Ph.D. at the same institution in 2007 and has since specialized in pharmaceutical and toxicological applications of cell and tissue culture. His research focuses on studying xenobiotics transport across biological barriers using human stem cell-derived in vitro models, particularly the blood-brain barrier (BBB). He has contributed to developing innovative BBB models for drug screening and collaborated with pharmaceutical companies and organizations like AstraZeneca. Dr. Culot coordinates the Master Tox & Ecotox program (MENACE), emphasizing New Approach Methodologies (NAMs) for toxicity assessment. He has led or participated in EU-funded projects, including FP7 Predict iv, H2020-ITN BtRAIN, and others, advancing in vitro toxicology and BBB modeling. His work integrates proteomics, cellular models, and computational tools to address neurovascular protection, drug permeability, and adverse outcome pathways. Culot’s lab develops strategies for predicting human neurotoxicity, improving drug delivery systems, and enhancing in vitro-to-in vivo extrapolation methods. His research spans interdisciplinary topics such as stem cell-derived BBB models, extracellular vesicle standardization (MISEV guidelines), and the impact of differentiation protocols on transcriptomic signatures. He also investigates challenges in oral biologic delivery and the application of NAMs to reduce animal testing reliance. Culot’s contributions bridge basic science and translational research, with a focus on advancing safer and more effective pharmaceutical and toxicological practices.

• Toxicology
• Nanomaterial Risk Assessment
• Induced Pluripotent Stem Cell (iPSC) Models
• +۳ مورد دیگر

Dr. Meike van der Zande is a Researcher at Wageningen University & Research , affiliated with the Team Toxicology . Her work focuses on developing in vitro models (e.g., iPSC-derived intestinal epithelial cells) to assess hazards of food additives, nanomaterials, and pharmaceuticals. She leads projects advancing animal-free testing strategies and contributes to regulatory frameworks for New Approach Methodologies (NAMs) in toxicology. Her research integrates transcriptomics, cell biology, and nanotoxicology to understand cellular responses to environmental and pharmaceutical exposures. Key projects include: Development of immunocompetent intestinal organoids for oral hazard assessment Qualification of NAMs for nanomaterial risk assessment in food/feed sectors Comparative studies of iPSC-derived cells vs. traditional models (e.g., Caco-2) Van der Zande has published over 46 peer-reviewed articles and datasets on topics like protein corona effects, Bayesian networks for nanomaterial hazard ranking, and fecal microbiome interactions. She actively collaborates across disciplines and participates in EU-funded projects (e.g., ACCORDs). Her work has been featured in media for advancing animal-free testing methodologies.

Vu Hoai Nam Dangمشاهده پروفایل

پژوهشگر

• Wildlife trade
• Wildlife farming
• One Health
• +۵ مورد دیگر

Vu Hoai Nam Dang is a postdoctoral researcher and Guest Researcher at the University of Copenhagen's Department of Food and Resource Economics, Section for Global Development. Holding a PhD in Economics (2022) from the University of Copenhagen and an MSc in Business Administration from KU Leuven (2012), he specializes in the economics of wildlife trade and conservation. Education: PhD in Economics, University of Copenhagen (awarded July 22, 2022) Master of Science in Business Administration, KU Leuven (awarded September 12, 2012) Dr. Dang's research focuses on wildlife trade economics, particularly examining consumer behavior regarding illegal wildlife products in Vietnam through choice experiments and behavioral theories. His work spans environmental economics, non-market valuation, and social marketing approaches to conservation. He leads the WILDRISK project investigating health risks in wildlife trade through the One Health approach, examining zoonotic disease transmission along wildlife value chains in Southeast Asia. His publication record shows a strong focus on rhino horn and tiger product consumption patterns, with recent 2025 publications indicating continued active research. His work combines economic valuation techniques with conservation science to inform policy interventions aimed at reducing demand for illegal wildlife products. Awards: SCIENCE PhD Award (2023) Dr. Dang serves as a peer reviewer for multiple conservation journals including Conservation and Society, Biological Conservation, World Development, and Journal of Social Marketing. He has co-supervised two MSc students and maintains active collaborations with international conservation organizations. His research has received significant attention, with media coverage from numerous news outlets and engagement across social media platforms. As a member of the Consortium on Compensating Income Variation (ConCIV) and the Global Initiative Network of Experts, Dr. Dang bridges academic research with practical conservation policy. His decade of experience working with UN Agencies across Europe and Asia provides valuable context for his academic work on international wildlife trade dynamics.

• Chemical Safety Assessment
• Safe and Sustainable by Design (SSbD)
• Toxicogenomics
• +۱۲ مورد دیگر

Dr. Angela Serra is a University Lecturer in the Department of Biomedicine at the Faculty of Medicine and Health Technology, Tampere University, Finland. Her research bridges computer science and biomedicine, focusing on data integration, toxicogenomics, and Safe and Sustainable by Design (SSbD) frameworks for chemical and nanomaterial safety assessment. Her primary research interests include chemical safety assessment , knowledge graphs in drug discovery , toxicogenomics , network toxicology , and computational modeling of adverse outcome pathways . She applies advanced data science and systems biology methods to develop innovative, non-animal approaches for evaluating chemical and nanomaterial risks. The recent publications highlight a strong trend toward integrated data frameworks , digital innovation in sustainability , and mechanistic modeling for regulatory science. Her work emphasizes the use of omics data, knowledge graphs, and AI-driven tools to support Safe and Sustainable by Design (SSbD) principles in chemical and material innovation. Dr. Serra is actively involved in EU-funded research, currently serving as a Work Package Leader in the INSIGHT project under Horizon Europe. She contributes to major collaborative efforts such as the PINK and CompSafeNano projects, advancing digital and data-driven approaches in toxicology and sustainability. She has developed several software tools including Nextcast , BMDx , and MaNGA , supporting toxicogenomics analysis, benchmark dose modeling, and QSAR modeling. These tools are publicly available and contribute to open science in computational toxicology.

John Kenneth Colbourneمشاهده پروفایل

استاد

• Environmental Genomics
• Evolutionary Ecology
• Toxicology
• +۵ مورد دیگر

John Kenneth Colbourne serves as Professor and inaugural Chair of Environmental Genomics at the University of Birmingham's School of Biosciences, where he also directs the Centre for Environmental Research and Justice (CERJ). He holds adjunct professorship at the Mount Desert Island Biological Laboratory and maintains leadership roles in multiple international genomics consortia. His research program integrates evolutionary ecology, high-throughput biology, and environmental genomics to investigate gene-environment interactions using Daphnia as a model organism. Key research areas include molecular mechanisms of developmental plasticity, genomic signatures for environmental health protection, forecasting ecological threats through Daphnia egg bank genomics, and biostatistical methods for high-dimensional data analysis. Analysis of his 15 most recent publications (2024-2025) reveals a strong focus on environmental toxicology, with particular emphasis on chemical mixture effects, neurotoxicity mechanisms, and the development of New Approach Methodologies (NAMs) for chemical safety assessment. His work demonstrates consistent application of Daphnia and zebrafish models alongside multi-omics approaches. Royal Society Wolfson Research Merit Award Co-chair of 2012-13 Gordon Research Conference on Ecological and Evolutionary Genomics Professor Colbourne actively collaborates with industry and advises government agencies on transforming environmental monitoring practices through molecular biology methods. He serves as Section-Editor for BMC Genomics, Founding Editor of Ecological and Environmental Genomics, and coordinates multiple BioMed Central publication series focused on Daphnia genomics. His leadership extends to founding roles in the Daphnia Genomics Consortium, Shanghai Consortium for Environmental Genomics and Toxicology, and several other international genome initiatives.

Anurag Chaturvediمشاهده پروفایل

پژوهشگر ارشد

• Evolutionary Genomics
• Epigenetics
• Toxicogenomics
• +۶ مورد دیگر

Dr. Anurag Chaturvedi is a Research Fellow at Clemson University's Center for Human Genetics (CHG), affiliated with the Department of Genetics and Biochemistry in the College of Science. He holds a PhD from KU Leuven (2017), followed by postdoctoral research at the Université de Lausanne and the University of Birmingham, supported by a Marie Skłodowska-Curie Fellowship (EU H2020). His research integrates evolutionary genomics, epigenetics, and toxicogenomics to study molecular mechanisms of chemical toxicity using Drosophila and other model organisms. Key focus areas include precision toxicology, adverse outcome pathways, and multi-omics data integration. Dr. Chaturvedi's work bridges fundamental research and applied toxicology, leveraging advanced genomic tools to identify biomarkers for environmental and anthropogenic chemicals. He has contributed to understanding rapid evolutionary adaptation in Daphnia populations and epigenetic regulation in mycorrhizal fungi. His research facilities include the Drosophila Genetic Reference Panel (DGRP) at CHG, enabling genetic dissection of toxic responses. Scientific awards include the prestigious Marie Skłodowska-Curie Fellowship (2017–2021). His labs are located across multiple facilities at the Self Regional Hall (Greenwood Genetic Center), including dedicated spaces for genomics and toxicology research. He actively collaborates in initiatives like the Precision Toxicology Consortium, advancing New Approach Methodologies (NAMs) for chemical risk assessment.

• Toxicology
• Colorectal Cancer
• Diet-Host-Microbiota Interactions
• +۲ مورد دیگر

Mette Helen Bjørge Müller is an Associate Professor in the Section for Experimental Biomedicine at the Norwegian University of Life Sciences. Her research focuses on toxicological effects using in vivo, ex vivo and in vitro models, with special expertise in food toxicants related to colorectal cancer and the interplay between diet, host physiology, and microbiota. She also develops New Approach Methodologies (NAMs) to study endocrine disruptors.

John Colbourneمشاهده پروفایل

استاد

• Environmental Genomics
• Evolutionary Ecology
• High-Throughput Biology
• +۶ مورد دیگر

John Colbourne is a Professor of Environmental Genomics at the Biosciences Centre for Environmental Research and Justice. His research integrates evolutionary ecology, high-throughput biology, and environmental genomics to study how organisms adapt to environmental challenges. He leads projects on chemical pollutants' molecular impacts, Daphnia genomics, and environmental DNA (eDNA) monitoring. Colbourne has secured funding from the European Commission, BBSRC, and the Food Standards Agency, and received a 2016 fellowship for his work on crustacean metabolism. He actively supervises PhD students in areas like genomic signatures for environmental health and computational methods for gene networks. Education: Not explicitly stated in provided texts Key Research Themes: Genomic responses to environmental stress, aquatic biodiversity monitoring, chemical safety methodologies His work contributes to UN Sustainable Development Goals related to clean water (SDG6), responsible consumption (SDG12), and life below water (SDG14). Recent projects include developing eDNA metabarcoding for riverine biodiversity and molecular mechanisms of sex determination in Daphnia. Colbourne has published 142+ articles and holds leadership roles in multi-national research consortia. Grants & Projects: 17 active/past projects including PrecisionTox (EU), MultiOmicsTox (EU), and Gnatwork sequencing validation Labs/Teams: Coordinates interdisciplinary teams focused on environmental genomics and computational toxicology

Luise Hennebergerمشاهده پروفایل

پژوهشگر

• Environmental Toxicology
• Exposure Science
• Toxicology
• +۳ مورد دیگر

Dr. Luise Henneberger is a Researcher and Group Leader of the “Bioassay exposure assessment” team at the Helmholtz Centre for Environmental Research – UFZ, within the Department of Cell Toxicology. She joined the Cell Toxicology Department in 2015 as a postdoctoral researcher and became a group leader in February 2020. Her expertise spans exposure assessment in cell-based bioassays, quantitative in vitro-to-in vivo extrapolation (QIVIVE), and the equilibrium sorption of ionogenic organic chemicals (IOCs) to proteins like serum albumin. Educations: Diploma in Food Chemistry (Martin Luther University Halle-Wittenberg) PhD at UFZ in Analytical Environmental Chemistry Her research focuses on advancing methodologies for environmental chemical exposure assessment, with contributions to tools like MLinvitroTox for high-throughput toxicity prediction. She actively participates in international conferences, such as SETAC Europe 2025, where her team presented work on New Approach Methodologies (NAMs) and chemical exposome assessment. Her team collaborates on industry-funded projects and contributes to innovative approaches in toxicology, emphasizing the transition from traditional testing to modern in vitro systems.